Stroke · 2006 · 277 citations · 25 references
MedicineNeurologyNeuroscienceClinical NeuroscienceCognitive NeuroscienceDementiaAlzheimer DiseaseCerebrovascular DiseaseCognitive DeclineCognitive ImpairmentDementia PrognosisDementia Risk FactorsAlzheimer Disease ProgressionAlzheimer Disease Vascular PathologyCerebral HemodynamicsCerebrovascular Reactivity TestingCognitive Impairment AssociationsPharmacological Treatment Of DementiaWhite Matter AbnormalitiesWhite Matter Lesions
BACKGROUND AND PURPOSE: The aim of this study was to explore the possible contribution of alterations in cerebral hemodynamics to the evolution of cognitive impairment in patients with Alzheimer disease (AD). METHOD: Fifty-three patients with AD were investigated. The evolution of cognitive decline over 12 months was evaluated by means of changes in Mini Mental State Examination (MMSE) and AD Assessment Scale for Cognition (ADAS-Cog) scores. Demographic characteristics, vascular risk profile, pharmacological treatment, and presence of white matter lesions were assessed at entry. Further, a basal evaluation of cerebrovascular reactivity to hypercapnia was measured with transcranial Doppler ultrasonography using the breath-holding index (BHI). RESULTS: Of all the variables considered, both MMSE and ADAS-Cog changes had the highest correlation with BHI, followed by age and diabetes. After subdividing both cognitive measures reductions into bigger and smaller-than-average decline (2 points for MMSE; 5 points for ADAS-Cog), multiple logistic regression indicated BHI as the sole significant predictor of cognitive decline. CONCLUSIONS: These results show an association between impaired cerebral microvessels functionality and unfavorable evolution of cognitive function in patients with AD. Further research is needed to fully establish whether altered cerebral hemodynamics may be considered an independent factor in sustaining cognitive decline progression or an effect of pathological processes involved in AD.
25
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
The Clinical Dementia Rating (CDR)
John C. Morris · Neurology · 1993 · 10K citations
Medicine, Neurology, Psychiatry +12
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
David A. Snowdon · JAMA · 1997 · 2K citations
Medicine, Neurology, Neuroscience +14
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Lars‐Olof Wahlund, Frederik Barkhof, Franz Fazekas et al. · Stroke · 2001 · 1.8K citations · Full text
John T. O’Brien, Timo Erkinjuntti, Barry Reisberg et al. · International Journal of Stroke · 2014 · 1.2K citations